Kornitzer Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
Other funds holding SUPN
RHJA
ACM
Kornitzer Capital Management's SUPN Position: Q3 2019 in Review
Kornitzer Capital Management sold out of Supernus Pharmaceuticals (SUPN) in Q3 2019, closing a stake of 106,899 shares — an estimated $3.54M sold.
Kornitzer Capital Management first reported a position in SUPN in Q3 2015 and held it in 16 quarters. The position peaked at $18.8M in Q3 2016. 243 funds tracked by Wall St. Rank hold SUPN as of Q3 2019.
- Kornitzer Capital Management reported no remaining Supernus Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
- Kornitzer Capital Management sold 106,899 Supernus Pharmaceuticals shares in Q3 2019, an estimated $3.54M.
- Kornitzer Capital Management first reported a position in Supernus Pharmaceuticals in Q3 2015 and held it in 16 quarters.
- Kornitzer Capital Management's Supernus Pharmaceuticals position peaked at $18.8M in Q3 2016.
- 243 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2019.
Based on Kornitzer Capital Management's 13F filing for Q3 2019, filed 4 Nov 2019.